GLOBAL PH Share Price

Stocks

GBLP

US37945N1090

OTC Markets Traded
Market Closed - OTC Markets 20:59:56 05/06/2026 BST 5-day change 1st Jan Change
0.0801 USD +60.18% Intraday chart for GLOBAL PH -.--% +60.20%
3 months+60.20%
6 months+60.20%

Valuation: GLOBAL PH

Market Cap 4.72M 4.13M 3.81M 3.5M 6.63M 454M 6.75M 45.47M 17.84M 222M 17.74M 17.35M 766M P/E 2006
-20.5x
P/E 2007 -4.23x
Enterprise Value 2.04M 1.79M 1.65M 1.51M 2.87M 196M 2.92M 19.66M 7.71M 96.02M 7.67M 7.5M 331M EV / Sales 2006
11.5x
EV / Sales 2007 4.95x
Free-Float
-
Yield 2006 *
-
Yield 2007 -
1 day+60.18%
3 months+60.20%
6 months+60.20%
Current year+60.20%
Current year 0.05
Extreme 0.05
0.08
1 year 0.05
Extreme 0.05
0.11
3 years 0.05
Extreme 0.05
0.35
5 years 0.05
Extreme 0.05
0.6
10 years 0.01
Extreme 0.008
0.9
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Director/Board Member - -

Financials

2006 2007
Net sales 2.38M 2.08M 1.92M 1.76M 3.34M 229M 3.39M 22.87M 8.97M 112M 8.92M 8.73M 385M 2.82M 2.46M 2.27M 2.09M 3.96M 271M 4.03M 27.14M 10.65M 133M 10.59M 10.35M 457M
Net income -1.23M -1.08M -996K -915K -1.73M -119M -1.76M -11.89M -4.66M -58.05M -4.64M -4.53M -200M -3.3M -2.88M -2.66M -2.45M -4.63M -317M -4.71M -31.76M -12.46M -155M -12.39M -12.12M -535M
Net Debt -2.68 -2.34 -2.16 -1.99 -3.76 -257.73 -3.83 -25.79 -10.12 -125.97 -10.06 -9.84 -434.18 -2.68 -2.34 -2.16 -1.99 -3.77 -257.99 -3.83 -25.82 -10.13 -126.1 -10.07 -9.85 -434.62
Logo GLOBAL PH
Global Pharmatech Inc is a company primarily engaged in the research, production and development of herbal medicine, bio-medicine, chemical medicine, traditional Chinese medicine (TCM) and dietary supplements. The Company’s main patented products include JUTAI SOFT CAPSULE, QINGXUAN ANTI-HYPERTENSION TABLET, YANREQING TABLET. The Company is also engaged in the manufacture and sales of other proprietary drugs, generics and dietary supplements used to treat symptoms ranging from headaches, coughing and dry mouth to infections and numbness of limbs. The Company also engages in the provision of biotechnology services, including research and development, testing, manufacturing drugs in liquid and solid dose forms, sales and marketing. The Company conducts its business in the domestic and overseas markets.
Employees
217
Sector
-
  1. Stock Market
  2. Stocks
  3. GBLP Stock